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Abstract
Background: Previous studies have shown that acute intake of high-phenol virgin olive oil reduces pro-inflammatory, 
pro-oxidant and pro-thrombotic markers compared with low phenols virgin olive oil, but it still remains unclear 
whether effects attributed to its phenolic fraction are exerted at transcriptional level in vivo. To achieve this goal, we 
aimed at identifying expression changes in genes which could be mediated by virgin olive oil phenol compounds in 
the human.
Results: Postprandial gene expression microarray analysis was performed on peripheral blood mononuclear cells 
during postprandial period. Two virgin olive oil-based breakfasts with high (398 ppm) and low (70 ppm) content of 
phenolic compounds were administered to 20 patients suffering from metabolic syndrome following a double-
blinded, randomized, crossover design. To eliminate the potential effect that might exist in their usual dietary habits, all 
subjects followed a similar low-fat, carbohydrate rich diet during the study period. Microarray analysis identified 98 
differentially expressed genes (79 underexpressed and 19 overexpressed) when comparing the intake of phenol-rich 
olive oil with low-phenol olive oil. Many of these genes seem linked to obesity, dyslipemia and type 2 diabetes mellitus. 
Among these, several genes seem involved in inflammatory processes mediated by transcription factor NF-κB, 
activator protein-1 transcription factor complex AP-1, cytokines, mitogen-activated protein kinases MAPKs or 
arachidonic acid pathways.
Conclusion: This study shows that intake of virgin olive oil based breakfast, which is rich in phenol compounds is able 
to repress in vivo expression of several pro-inflammatory genes, thereby switching activity of peripheral blood 
mononuclear cells to a less deleterious inflammatory profile. These results provide at least a partial molecular basis for 
reduced risk of cardiovascular disease observed in Mediterranean countries, where virgin olive oil represents a main 
source of dietary fat. Admittedly, other lifestyle factors are also likely to contribute to lowered risk of cardiovascular 
disease in this region.
Background
Metabolic syndrome (MetS) is a very common condition
that is associated with increased cardiovascular disease
(CVD) risk and type 2 diabetes mellitus, itself a risk factor
for CVD. Its diverse clinical characteristics illustrate the
complexity of the disease, involving several dysregulated
metabolic pathways and multiple genetic targets. When
caloric intake exceeds caloric expenditure, a positive
caloric balance and subsequent storage of fat in adipose
tissue appears; this often is cause of adipocyte hypertro-
phy and obesity. Depending on interaction of genetic and
environmental factors, this hypertrophy can be followed
by macrophage accumulation within adipose tissue lead-
ing to local hypoxia, inflammation, and oxidative stress.
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Page 2 of 11These deleterious effects favor adipose functional failure
resulting in changes in systemic energy delivery; these
also impair glucose consumption and activate self-regula-
tory mechanisms that extert influence over whole body
homeostatic systems and link obesity to numerous health
problems associated with MetS [1]. A low-level systemic
chronic inflammation, with abnormal cytokine produc-
tion in adipose tissue, increased acute-phase reactants,
and activation of inflammatory signaling pathways, often
acting over a period of many years, appears to constitute
a potential link to atherosclerosis development in these
patients [2]. In addition, changes in postprandial metabo-
lism undergoing every time we have a meal as well as
alterations in this state may play an important role in the
development of cardiovascular and cardiovascular associ-
ated diseases [3]. Moreover, Van Oostromet et al. [4] pro-
vides evidence that postprandial triglyceridemia is related
to a pro-inflammatory state due to high expression of
markers of neutrophilic and monocyte activation.
The anti-atherogenic effects associated with Mediterra-
nean Diet (MD) rich in Virgin Olive Oil (VOO) consump-
tion, could contribute in explaining the low rates of
cardiovascular mortality found in Southern European
Mediterranean countries, in comparison with other
Western populations [5]. It has been demonstrated
recently that inhibition of circulating immune cell activa-
tion could be a protective mechanism by which MD
exerts its healthy effects [6]. Bonani et al. [7] showed that
extra VOO consumption reduces inflammatory markers
and increase serum antioxidant capacity at postprandial
state. Previously, our group has showed how a VOO-rich
MD, during postprandial state, reduces inflammatory
response of peripheral blood mononuclear cells (PBMCs)
mediated by transcription factor NF-κB, when compared
to, butter and walnut-enriched diets or Western diets
[8,9]. These results have been replicated by others and
support the hypothesis that decreasing NF-κB pathway
activation is a mechanism involved in the anti-inflamma-
tory effect of a VOO-rich MD [10,11]. Nevertheless, it
has been proposed that healthy effects of VOO may be
due not only to its oleic acid content but also to the anti-
oxidant and anti-inflammatory capacity of minor compo-
nents, especially the phenol-rich fraction [12,13]. Our
group demonstrated that the VOO phenol fraction also
improves endothelial dysfunction and haemostatic profile
during postprandial state [14,15]. Other studies showed
how these compounds ameliorate lipid profiles and
decrease oxidative stress in vivo [12]. However, in animal
models, it has been showed that hydroxytyrosol, a phenol
found in olive oil, administered after being extracted
from its original matrix could be not only non beneficial
but indeed harmful for health [16].
It has been speculated that potentially beneficial effects
could be due to olive oil modulation on genes involved in
proliferative, antioxidant and inflammatory pathways. In
order to clarify this question, some human, animal mod-
els and in vitro studies were undertaken using gene
expression microarray platforms [17]. These studies
showed that olive oil is able to modify gene expression
coding for proteins participating in cellular mechanisms
involved in oxidative stress resistance [18], lipid metabo-
lism [19] and other atherosclerosis-related traits/path-
ways [20,21]. Nonetheless, it is unresolved whether these
changes in gene expression are mediated by oleic acid or
executed by olive oil polar minor components, maybe as a
consequence of their antioxidant capacity, or by interact-
ing directly with receptors, enzymes or transcription fac-
tors. To date, no intervention studies in humans have
thoroughly explored the effects of VOO phenol com-
pounds on gene expression. Thus, the main purpose of
this study was to identify genes which undergo changes in
expression in PBMCs in patients with MetS, after acute
intake of breakfast based in phenol-rich virgin olive oil,
compared to phenol-poor olive oil breakfast.
Results
Postprandial metabolic parameters
No significant differences were observed in any of the
iAUCs of the main metabolic variables (glucose, insulin,
non-sterified fatty acids, serum triglycerides and high
density lipoprotein cholesterol) after intake of phenol-
rich virgin olive oil compared with olive oil with lower
content of these compounds (Table 1).
Microarray results and selection of candidate genes
Two color microarrays experiments were performed by
using Agilent platforms; 45,220 probe sets were tested to
interrogate the expression of 30,886 unique human genes.
Microarray analysis showed a correlation index >90% of
the raw log-intensity signal among replicates in the array
in all cases. Mean coefficient of variation of the log-signal
probe values was lower than 0.1 for intra-array replicates.
Changes in gene expression were determined as log2 ratio
of signal intensity values corresponding to transcripts
present 4 hours after intake of olive oil with high phenol
content, divided by the signal intensity values, which cor-
respond to transcripts present 4 hours after consumption
of low phenol content olive oil. 15,308 high-quality
probes were selected ranging from 1.89 to -1.79 log2 ratio.
In these, we found 98 genes differentially expressed in
human PBMCs (Additional File 1), selecting log2 ratio
greater than 0.4 (more expression after intake of olive oil
with high phenol content, this is, at least 1.32 fold, in 19
over-expressed genes) or log2 ratio lower than -0.4 (less
expressed after consumption of high phenol content olive
oil; this is, at least 1.32 fold, in 79 under-expressed genes)
with a statistical significance (p) for the fitted linear
model of = 0.01. Results were adjusted by dye-swap
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jamini and Hochberg method. The most under-expressed
genes in MetS patients during postprandial period after
intake of olive oil phenols were G0S2, EGR2, EGR1,
FOSB, IL1B, NR4A2, EGR3, RASGEF1B, CXCL1 and
PTGS2 (1.95- to 2.74 fold) and the most over-expressed
genes were CA1, RAP1GAP, GYPB, FN1 and SELENBP1
(1.46- to 1.57- fold). Additionally, we performed a gender
analysis (Additional File 2). From these, we found 32
genes differentially expressed in the analysis for both,
men and women. However, 329 genes were differentially
expressed only for men (218 genes) and only for women
(111 genes).
Results validation by qRT-PCR
To confirm microarray results using an independent
technique, log2 of the normalized microarray ratio values
were compared with log2 ratio values for four genes
obtained from qRT-PCR experiments (JUN, PTGS2,
EGR1 and IL1B). Results showed that features of the
changes in both procedures were similar with Spearman r
coefficients between 0.901 and 0.968 and p-values less
than 0.001 (Figure 1 and 2).
Pathway analysis
In order to investigate functional relationships in the set
of differentially expressed genes, we used the Ingenuity
Pathway Analysis Software [22] (Ingenuity Systems, Red-
wood City, CA USA) which employs a predefined knowl-
edge base containing over 10.000 curated human genes.
Of the 98 differentially expressed genes found in patients
with MetS during the postprandial period after intake of
olive oil phenols, two transcripts (LOC284454,
AF351612) showed no entries within the knowledge base
and only 81 genes were eligible for network analysis.
Inflammatory disorder was the most highly represented
disorder (39 genes, p = 2.11E-19). From these, 35 genes
(PTGS2, IL1B, IL6, OSM, CCL3, CXCL1, CXCL2, CXCL3,
CXCR4, NAMPT, DUSP1, DUSP2, EGR1, EGR2, EGR3,
EREG, FOSB, G0S2, JUN, JUNB, NFKBIA, NFKBIZ,
NR4A1, NR4A2, PER1, SOCS3, SOD2, TAGAP, TNFAIP3,
ZFP36, AREG, CA2, CD69, CD83, CDKN2A) were under-
expressed and after intake of virgin olive oil with high
content in phenolic compounds, 4 genes were over-
expressed (CCR2, CA1, CPVL, FN1). Cellular functions
most strongly associated with the differentially expressed
genes were cell death (41 genes, p = 7.53E-11), cell migra-
tion (24 genes, p = 3.88E-8), cell division (23 genes, p =
6.29E-8), cell proliferation (32 genes, p = 9.90E-7) and
transcription (25 genes, p = 3.55E-05). Network analysis
yielded 14 different sub-networks, from which, one was
identified as preferentially enriched by genes found dif-
ferentially expressed after high-phenol VOO intake. This
top-scoring sub-network included 26 genes whose related
top-function was 'inflammatory diseases' with a probabil-
ity value of 10-54 (Fisher's exact test) of gene interrelation-
ships being by chance. All sub-networks were merged to
obtain the overall network shown in Figure 3. Interacting
proteins were added using Ingenuity Pathways Knowl-
edge Base database. Finally non-connected genes or those
connected by two or more edges were removed, except
for those genes that were found to be differentially
expressed in our microarrays analysis.
Discussion
In the present study, we have observed that the phenol
fraction of VOO in vivo is able to repress the expression
of several genes related to inflammation pathways in
patients with MetS during postprandial period (Addi-
tional File 1). This finding draws interest since pro-
inflammatory state remains as one component of MetS
[23] and low-grade inflammation is often associated with
endothelial dysfunction [24], which by itself is associated
to the development of atherosclerosis [25].
The PTGS2 gene encodes prostaglandin-endoperoxide
synthase 2 (COX-2), an inducible isozyme involved in
Table 1: Postprandial metabolic parameters.
Low-phenol
OO breakfast
High-phenol
OO breakfast
p value
iAUC Glucose (mg.dL-1. min-1) 1775 ± 5156 1556 ± 2661 0.876
iAUC Insulin (U.L-1.min-1) 3722 ± 2904 4141 ± 2239 0.627
iAUC NEFA (mmol.L-1.min-1) -4257 ± 3321 -4029 ± 2626 0.990
iAUC TG (mg.dL-1. min-1) 4256 ± 3504 4277 ± 6441 0.995
iAUC HDLc (mg.dL-1. min-1) 112 ± 689 135 ± 1036 0.395
Incremental area under the postprandial serum concentration curve (iAUC) of glucose, insulin, NEFA, TG and HDLc after the acute intake of 
both types of olive oil. OO, olive oil; p values correspond to Wilcoxon-paired test (n = 20); iAUC, incremental area under the concentration 
curve; NEFA, non-sterified fatty acids; TG, serum triglycerides; HDLc, high density lipoprotein cholesterol. All values are expressed as mean ± 
SD.
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strate. In macrophages, and other cells, COX-2 activity is
rapidly increased by various stimuli, such as pro-inflam-
matory cytokine IL1β. Substantial evidence indicates that
up regulated PTGS2 expression and prostaglandin syn-
thesis indeed influence chronic inflammatory conditions
[26]. De la Puerta et al. observed that murine mac-
rophages showed significantly reduced IL1β production
and COX-2 activity after olive oil-enriched diet [27].
Recently, it has been demonstrated that hydroxytyrosol,
one of the most important phenol compounds found in
virgin olive oil, attenuates in vitro LPS-induced transcrip-
tion of PTGS2 [28]. Our study showed that in vivo intake
of phenol-rich virgin olive oil in humans is associated
with a decreased expression of both IL1B and PTGS2, as
compared to low-phenol olive oil intake. Those effects
could contribute to reduced inflammation during post-
prandial state in agreement with anti-inflammatory
effects observed after VOO-rich MD consumption [8,9].
The cytokine-cytokine interaction pathway contains a
network of proteins (chemokines and their receptors)
involved in the recruitment and activation of leukocytes
during inflammatory response. Expression of genes such
as CCL3, CXCL1, CXCL2, CXCL3, CXCR4, IL1B, IL6, and
OSM is described under-expressed after acute intake of
phenol-rich olive oil in our intervention study on diet.
CCL3 gene, which codes for macrophage inflammatory
protein-1 (MIP-1), has been implicated in monocyte infil-
tration of adipose tissue, an action that could significantly
influence a pro-inflammatory pattern within endothelial
cells [29]. CXCL1, CXCL2 (MIP2A), and further, CXCL3
(MIP2B) are genes for small and structurally related
chemokines that regulate cell trafficking of various types
of leukocytes through interactions with a subset of G pro-
tein-coupled receptors. Elgazar-Carmon et al. have dem-
onstrated in mice that early neutrophil infiltration of
adipose tissue may be mediated by CXCL1, a process that
would precede macrophage infiltration after long-term
consumption of a high-fat diet [30]. IL6 encodes a
cytokine which is secreted to serum and induces a tran-
scriptional response involved in a wide variety of inflam-
mation-associated conditions, including MetS and type 2
diabetes mellitus (T2DM) [31]. On the other hand, it has
been proposed that IL6 and OSM, which encodes
Figure 1 Microarrays results validation by qRT-PCR. Mean ( ± S.E.M.) of relative expression values after the consumption of low and high phenol 
content olive oil. One way ANOVA p value is showed. Gene expression values were log transformed before statistical analyses.
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Page 5 of 11oncostatin M, a growth regulator and member of the IL6
group of cytokines, can contribute to the increased car-
diovascular risk in obese patients by up regulating PAI -1
in adipose tissue [32].
Activation of NF-κB and MAPK pathway, a cascade of
phosphorilation events that result in the activation of
transcription factors like CREB and AP-1, synergize for
expression of inflammatory genes through coordinate
bindings of transcription factors to κB and AP-1 sites
which have been found together in the promoters of e.g.
IL6 and TNF-α, and many other inflammatory genes [33].
Chemokine repression found in our study could be con-
sequence of phenols interaction with this inflammation
signaling system, since expression of some genes involved
in NF-κB/MAPK/AP-1 signaling pathways was also mod-
ulated after phenol-rich olive oil based breakfast. NF-κB
is a transcription factor activated by pro-inflammatory
cytokines [34] and oxidative stress mediators [35].
Recently Pierce et al. have demonstrated that NF-κB acti-
vation is important in mediating vascular endothelial dys-
function in obese humans [36]. The product of SGK1
gene, encoding a serum/glucocorticoid regulated kinase
with a role in stress response and by itself being a down-
stream target for PI3K signaling, enhances nuclear NF-κB
activity by phosphorylating an inhibitory kinase IKKα
[37]; so repression on expression of SGK1 gene by olive
oil phenols would decrease the NF-κB activation. In addi-
tion, NFKBIA gene, which encodes to IκBα, a member of
an inhibitory IκB family that retains NFκB into the cyto-
plasm, remained under-expressed after acute intake of
phenol-rich olive oil. It has been reported that NF-κB
binds to the IκBα promoter in order to activate its tran-
scription [38]. Thus, this negative feedback mechanism
results in rapid cycles of inhibition and stimulation of
NF-κB where a decrease on NF-κB activation is accompa-
nied by a reduction on NFKBIA gene expression, as
observed in our results. The hypothesis that NF-κB acti-
vation is decreased by olive oil phenols is also supported
by two in vivo studies which showed reduced NF-κB acti-
vation after olive oil consumption [8,9]. Additionally, in
vitro studies showing attenuated NF-κB activation by res-
veratrol support the hypothesis that this pathway
employs a shared mechanism by which polyphenols
reduce expression of genes encoding inflammatory
cytokines and adhesion molecules [39].
After intake of virgin olive oil with high content in phe-
nolic compounds we found a decreased postprandial
expression of DUSP1 and DUSP2. Those genes encode
dual serine-threonine phosphatases, which down regu-
late members of p38, MAPK/ERK and SAPK/JNK, the
three final effectors of the MAPK pathway [33]. In addi-
tion, TRIB1, another gene repressed by phenol-rich olive
oil, is involved in MAPK signaling, participating in the
activation of ERK proteins [40] and being up regulated in
human atherosclerotic plaques [41]. Thus, reduction of
TRIB1 expression by olive oil phenols could promote
decreased ERK activation. This observation agrees with
in vitro studies demonstrating that phenol compounds of
green tea down regulate PTGS2 expression by decreasing
ERK and p38 MAPK activation [42]. Our results allow us
to hypothesize that olive oil phenols influence activation
of AP-1, which consists of a variety of heterodimers of
Jun, Fos and activating transcription factor families [43],
by means of two different mechanisms: a) one direct,
involving repression of JUN, JUNB and FOSB as observed
after phenol-rich olive oil intake; and/or b) another one
indirect, through MAPK pathway, where the relative
intensity and duration of activation determine the type of
response.
Lastly, biomedical literature and text mining tasks were
performed to identify interactions of differentially
expressed genes in PBMCs as response to phenol-rich
VOO with conditions clustered around MetS such as
obesity, hypertension, dyslipemia, hyperglycemia, or
T2DM. Recently, Chen et al. have described a mac-
rophage-enriched gene network (MEGN) of ~1237 genes
referred as having causal relationship with complex-dis-
ease traits associated with MetS [44]. Thirteen genes
share our set of differentially expressed genes in PBMCs
after acute intake of phenol-rich olive oil and MEGN:
JUN, RGS1, CXCL2, ANXA3, RASGEF1B, CD83, CA2,
EGR2, DIAPH3, CCL3, and TLR7, PSAP and IFIT3. De
Mello et al. assessed individuals with both impaired glu-
cose metabolism and MetS on how long-term weight loss
affects expression of cytokines in PBMCs. Weight reduc-
Figure 2 Correlation between microarrays and qRT-PCR results. 
Correlation analysis between log2 ratio of the gene expression values 
from microarrays and qRT-PCR experiments. Ratio of the gene expres-
sion values correspond to gene expression after consumption of high 
phenol content olive oil divided by gene expression after the con-
sumption of low phenol content olive oil. Spearman r values are shown 
in the graphs.
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Page 6 of 11tion resulted in a decrease in of IL1B expression [45]. Kai-
ser et al. showed by microarrays analysis in PBMCs a set
of 22 over-expressed genes in T1DM and T2DM com-
pared to healthy subjects [46]. Interestingly, 8 of the iden-
tified 22 over-expressed genes in T2DM were repressed
by olive oil phenols, according to our intervention study
(IL1B, EGR2, EGR3, PTGS2, FOSB, CXCL1, SGK, and
TRIB1). In addition, PBEF1, another gene involved in the
pathogenesis of T2DM [47], was also found repressed
after consumption of phenols-rich olive oil. Taken
together, this finding could lead to potential therapeutic
implications in T2DM.
Figure 3 Ingenuity Pathway Analysis Network. Network of phenol-rich VOO modulated genes. Gray symbols denote that the gene was found 
over-expressed or under-expressed by phenols in microarrays analysis.
Extracellular Space
Citoplasm
Nucleus
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Page 7 of 11Conclusions
Our study shows that intake of breakfast based in virgin
olive oil being rich in phenol compounds is able to
repress expression of several pro-inflammatory genes in
vivo, thereby switching activity of PBMCs to a less delete-
rious inflammatory profile. These results provide at least
a partial molecular basis for risk reduction of cardiovas-
cular disease observed in Mediterranean countries,
where VOO represents a main source of dietary fat.
Admittedly, other lifestyle factors are also likely to con-
tribute to lowered risk of CVD in this region. Nonethe-
less, our data suggest that mechanisms by which these
micronutrients in phenol-rich olive oil would exert their
anti-inflammatory effect could involve pathways related
to NF-κB/AP-1, cytokine-cytokine receptor interaction,
arachidonic acid metabolism, and MAPK. These findings
strengthen the relationship between inflammation, obe-
sity and diet and provide evidence at transcription level of
control of healthy effects derived from VOO consump-
tion in humans. However, it would be interesting to eval-
uate whether these beneficial effects are maintained after
prolonged feeding and if these effects are carried out by
one or several olive oil phenolic compounds, or if they are
consequence of a synergic effect of the total phenolic
fraction.
Methods
Subjects
Twenty (56 years old; range, 40-70) subjects (9 men, 11
women) from the Lipids and Atherosclerosis Unit at Hos-
pital Universitario Reina Sof ía (Cordoba, Spain) partici-
pated in this study.
All subjects fulfilled three or more of the proposed cri-
teria proposed by the Third Report of the National Cho-
lesterol Education Program (NCEP) Expert Panel on
Detection, Evaluation, and Treatment of High Blood
Cholesterol in Adults (Adult Treatment Panel III) for
MetS: a) central obesity (waist circumference > 102 cm in
men or > 88 cm in women); b) high blood pressure ≥ 130/
85 mmHg or documented use of antihypertensive ther-
apy; c) high fasting glucose (≥ 100 mg.dL-1); d) hypertrig-
lyceridemia (≥ 150 mg.dL-1), and e) low high density
lipoprotein cholesterol (HDLc) (< 40 mg.dL-1 for males or
50 mg.dL-1 for females). Subjects had an average body
mass index (BMI) of 38.98 (27.95-44.42) kg.m-2, waist
perimeter of 132.2 cm (103.0-137.0), systolic blood pres-
sure of 146 ± 19 mmHg, diastolic blood pressure of 89 ±
10 mmHg, plasma glucose levels of 102.8 ± 17.0 mg.dL-1,
plasma insulin levels of 11.5 ± 6.5 mU.L-1, total choles-
terol (TC) plasma levels of 201.7 ± 27.1 mg.dlL-1 triacylg-
lyceride (TAG) plasma levels of 185 ± 78 mg.mL-1, low
density lipoprotein cholesterol (LDLc) levels of 120.3 ±
19.7 mg.dL-1 and high density lipoprotein cholesterol
(HDLc) levels of 50.7 ± 11.8 mg.dL-1. No subjects showed
evidence of chronic diseases (hepatic, renal, thyroid, car-
diac), smoking, alcohol consumption, or family history of
cardiovascular disease of early onset, nor were they tak-
ing drugs. The Human Investigation Review Committee
at Reina Sofia University Hospital approved this study. All
participants gave informed consent before joining the
study.
Study design and dietary intervention
Before the first breakfast intervention, participants fol-
lowed a 6-week washout period in which they were
instructed to not take vitamins, soy supplements, or any
drug. To eliminate the potential effect that might exist in
their usual dietary habits, all subjects followed a low-fat,
carbohydrate rich (CHO) diet during this period through
the end of the study. Compliance with the CHO diet was
assessed after two and four weeks using a three-day
recording and a food frequency questionnaire. 24 hours
prior to each breakfast intervention, participants were
instructed to avoid consuming phenol-rich foods such as
fruit or juices, wine, grape juice, chocolate, coffee, tea,
olive oil, or soy, and to refrain from intense physical exer-
cise. After a 12-h fast and following a randomized
sequential crossover design with one-week washout
period, participants reported to the hospital and received
two fat meals consisting of 60 grams of white bread, 40
mL of VOO (CANOLIVA®, Antonio Cano e Hijos™, Cor-
doba, Spain) with high (398 ppm) or low (70 ppm) con-
tent in phenolic compounds, and 60,000 IU of vitamin A
per m2 of body surface. Throughout the 4-hour duration
of the study session, subjects performed no physical
activity, nor did they consume anything but water.
Olive oil characteristics
Olive oil with low content in phenolic compounds was
obtained by physical extraction of most phenolic com-
pounds from the high-phenol olive oil, so that both oils
retained a similar composition of the remaining macro-
and micro-nutrients with the exception of phenolic con-
tent (70 ppm vs 398 ppm) (data not shown). Hydroxyty-
rosol content was 0.2 μmol.g-1 and 45.4 μmol.g-1,
respectively in low-phenol and high-phenol olive oil.
High-phenol olive oil was washed in separating funnels
with the same volume of distilled water. This operation
was repeated seven times at room temperature under
reduced light to avoid oxidation. Fatty acid composition
of oils was determined by gas chromatography in a Per-
kin-Elmer Autosystem (SGE Scientific, Australia) accord-
ing to EU Regulation 2568/91 (CE, 1991). Tocopherol
composition was analyzed by HPLC in a Perkin-Elmer
HPLC, applying IUPAC method 2432 (IUPAC, 1992).
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Page 8 of 11Sample collection
Venous blood samples were obtained at 0, 30, 60, 120 and
240 min after consumption of each breakfast. Samples
from fasting and postprandial states were collected in
tubes containing 1 g EDTA/L and stored in containers
with iced water and kept in the dark. Special care was
taken to avoid exposure to air, light, and ambient temper-
ature. Plasma was separated from whole blood by low-
speed centrifugation at 1500 × g for 15 min at 4°C within
the hour after extraction.
Lipid analysis and biochemical determinations
Lipid parameters were assessed with the modular autoan-
alyzer DDPPII Hitachi (Roche, Basel, Switzerland), using
specific reagents (Boehringer-Mannheim, Mannheim,
Germany). Determinations of TC and TAG levels were
made by colorimetric enzymatic methods [48,49]; of
HDLc by colorimetric assay [50]; of LDLc by the Friede-
wald formula based on CT, TAG, and HDLc values [51].
Plasma glucose concentrations were measured with a
Hitachi 917 analyzer (Boehringer Mannheim, Mannheim,
Germany) by the glucose oxidase method (GOD-PAP).
Plasma insulin concentrations were measured by
microparticle enzyme immunoassay (Abbott Diagnostics,
Matsudo-shi, Japan). Nonsterified fatty acid concentra-
tions were measured by enzymatic colorimetric assay
(Roche Diagnostics, Penzberg, Germany).
Isolation of PBMCs
PBMCs were isolated within 2 hours after blood draw
from 30 mL EDTA anticoagulated blood samples taken 4
hours after consumption of each olive oil-based break-
fast. Buffy coats were diluted 1:2 in PBS, and cells were
separated in 5 mL Ficoll gradient (lymphocyte isolation
solution, Rafer) by centrifugation at 2000 × g for 30 min.
PBMCs were collected and washed twice with cold PBS.
Harvested PBMCs were preserved in liquid nitrogen and
stored at -80°C prior to RNA extraction.
RNA extraction and microarray samples preparation
Total RNA was extracted from mononuclear cells with
TRI Reagent (Sigma-Aldrich, Inc., St. Louis, MO, USA)
and purified with RNeasy MiniElute Cleanup Kit (Qia-
gen, Hilden, Germany). Recovered RNA was quantified
using a Nanodrop ND-1000 v3.5.2 spectrophotometer
(Nanodrop Technology®, Cambridge, UK). RNA integrity
was assessed using 1.6% agarose gel, 1× TBE. RNA was
judged suitable for array hybridization only if samples
exhibited intact bands corresponding to 18S and 28S
ribosomal RNAs.
Microarray analysis design
Gene expression profiles were generated using the 4x44K
glass slide Whole Human Genome Oligo Microarray
G4112A (Agilent Technologies Inc., Santa Clara, CA,
USA). Each microarray uses 45,220 probes to interrogate
30,886 unique human genes and transcripts. Two sets of
dye-swapped experiments were performed to total four
replicate hybridizations per subject (totals 80 microarray
experiments). Each array compared total RNA from
PBMCs obtained 4 hours after intake of virgin olive oil
with high phenolic content with RNA obtained 4 hours
after low-phenol virgin olive oil consumption.
Synthesis and labeling of cDNA
RNA samples were labeled using the SuperScript Indirect
RNA Amplification System (Invitrogen Inc., Carlsbad,
CA, USA) according to the manufacturer's instructions.
To avoid confounding by extraneous factors, all experi-
ments were performed in a single batch and processed by
one researcher on the same day for each step. Dye incor-
poration rates were assessed with a Nanodrop® ND-1000
v3.5.2 spectrophotometer (Nanodrop Technology®, Cam-
bridge, UK) and found to be between 8 and 12 pmol. μL-1.
Microarray hybridation and scan protocol
Differentially labeled aRNA samples were cohybridized
on microarray slides. Hybridization was performed using
the Gene Expression Hybridization Kit (Agilent Technol-
ogies Inc., Santa Clara, CA, USA) following the manufac-
turer's instructions. Microarray images of each slide were
obtained with a Gene Pix 4000B scanner (Axon Instru-
ments, Union City, CA, USA). Image quantization was
performed using Agilent Feature Extraction Software
v9.5 (Agilent Technologies Inc., Santa Clara, CA, USA).
Preprocessing and normalization of the microarray data
Background adjusted signals (BGSubSignal) were calcu-
lated by the Agilent Feature Extraction Software (v9.5)
and filtered on the flag IsWellAboveBG. Log2 dye
swapped (red/green) mean-centered signal ratio data
were normalized within-array and between-array by
Lowess and quantile methods respectively, both imple-
mented in the R Limma package (GLP).
Differential gene expression analysis
Identification of genes whose expression could be regu-
lated by virgin olive oil phenols was done by comparing
microarray results from PBMCs obtained at 4 hours after
high and low phenol olive oil ingestion. Differential gene
expression analysis was performed by fitting of gene-wise
linear models to microarray data with R Limma package
(GLP). For considering a gene as differentially expressed,
filtering criteria were used combining M value (signal
log2 ratio) greater than 0.4 (over-expressed) or lower than
-0.4 (under-expressed) (by 1.32 and -1.32-fold changes,
respectively), and statistical significance (p) of the fitted
linear model of ≤ 0.01 for every gene. Results were
Camargo et al. BMC Genomics 2010, 11:253
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(FDR) using Benjamini and Hochberg method.
MIAME Gene Expression Omnibus (GEO) database
Raw microarray data have been curated and accepted in
GEO (a public repository for microarray data, aimed at
storing MIAME (Minimum Information About Microar-
ray Experiments) compliant data in accordance with
MGED (Microarray Gene Expression Data) recommen-
dations. Access to data concerning this study may be
found under GEO experiment accession number
GSE15812 http://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?token=pjihtumyoyogmhy&acc=GSE15812.
qRT-PCR analysis of differentially expressed genes
PCR analyses were performed using Mx3005 Thermocy-
cler (Agilent Technologies, La Jolla, CA) and iQ
SYBR®Green Supermix (Bio-Rad Laboratories, Inc., Her-
cules, CA, USA) commercial kit in a final volume of 20 μl
with 10 pmol of each primer. Each reaction was per-
formed on 1 μl of 1:5 (v/v) dilution of the first cDNA
strand, synthesized using 1 μg of total RNA by the com-
mercial kit iScript® cDNA Synthesis Kit (Bio-Rad Labora-
tories, Inc., Hercules, CA, USA) according to the
manufacturer's instruction. The reaction was incubated
at 96°C for 3 min, followed by 40 cycles of 30 s at 96°C, 30
s at 62°C, 20 s at 72°C and 10 s at 80°C where fluorescence
was measured to avoid primer-dimer and background
signals. Primers used were: ERG1-Up (5'-CTACGAG-
CACCTGACCGCAGAG-3'), ERG1-Low (5'-CCAGG-
GAAAAGCGGCCAGTATAG-3'), JUN-Up (5'-
GACCTTCTATGACGATGCCCTCAA-3'), JUN-Low
(5'-ACGTCGGGCGAGGTGAGGAGGTC-3'), IL1B-Up
(5'-GGGACAGGATATGGAGCAACAAGT-3'), IL1B-
Low (5'-GCTTATCATCTTTCAACACGCAGGA-3'),
PTGS2-Up (5'-ATGAGTTATGTCTTGACATCCAGAT-
CAC-3'), PTGS2-Low (5'-CAAACATCATGTTTGAGC-
CCTGG-3'), RPL13-Up (5'-
CCTGGAGGAGAAGAGGAAAGAGA-3') and RPL13-
Low (5'-TTGAGGACCTCTGTGTATTTGTCAA-3').
Specificity of PCR amplifications was verified by a melt-
ing curve program (60-95°C with a heating rate of 0.5°C/s
and a continuous fluorescence measurement) and ana-
lyzed by electrophoresis on a 1.6% agarose gel, TBE 1×.
Primer efficiencies were: EGR1, 98%; PTGS2, 101%; IL1B,
96%; JUN, 108%; RPL13a, 95%. Expression values were
obtained as relative expression of the target gene versus
the constitutively expressed RPL13a gene (relative
expression = 2-(Ct, Target gene-Ct, Reference gene)).
Statistical analysis
Several variables were transformed to define the meta-
bolic postprandial response after acute intake of both
types of olive oil. Incremental area under plasma concen-
tration curve (iAUC) was calculated for all measured
metabolic variables by the trapezoidal method. The nor-
mality of data was assessed using the Saphiro-Wilk test.
Log transformation of data was performed when those
variables were not normally distributed. Differences
between iAUC after intake of high-phenol and low-phe-
nol olive oils were analyzed using Wilcoxon-paired test.
For data analysis, gene expression data were presented
in M-values [log2(ratio)] expressing a fold change after
high-phenol olive oil intake compared to low-phenol
olive oil consumption. The corresponding p-value, B-
value, and B-probability are shown (Additional File 1).
The data input for correlation analysis using Spearman's
test were the log2(ratio) value for microarrays (M-value)
and qRT-PCR in subject individuals.
All data presented in the text and tables are expressed
as mean ± SD unless otherwise specified. Significance
levels were set to p-values less than 0.01 for microarray
data and less than 0.05 for all other analyses. All statistical
tests were performed using R programming and statisti-
cal environment software (GLP).
Abbreviations used
ppm: part per million; MetS: metabolic syndrome; CVD:
cardiovascular disease; VOO: virgin olive oil; MD: Medi-
terranean Diet; PBMC: peripheral blood; mononuclear
cells; MEGN: macrophage-enriched gene network.
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